Clinical Trial Update: Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 (P08599) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial NCT01641666 evaluating the safety and tolerability of Boceprevir in combination with peginterferon alfa-2b plus ribavirin in Vietnamese s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)
• Peginterferon alfa-2b (Peginterferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C | Phase 3 | Status: WITHDRAWN